SES AI Corporation (SES) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SES AI Corporation ("SES" or "the Company") (NYSE:SES). Investors who purchased SES securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SES. […]

Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zenas BioPharma, Inc. ("Zenas BioPharma" or "the Company") (NASDAQ:ZBIO). Investors who purchased Zenas BioPharma securities prior to September 13, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ModivCare, Inc. (MODV) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV). Investors who purchased ModivCare securities prior to November 3, 2022, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to

PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS" or "the Company") (NYSE:PACS). Investors who purchased PACS securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Encourages Charter Communications, Inc. (CHTR) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Charter Communications, Inc. ("Charter" or "the Company") (NASDAQ:CHTR). Investors who purchased Charter securities prior to July 26, 2024, and continue to hold to the present, are encouraged to obtain

Local Plumbing and Drain Company Continues Delivering Trusted Plumbing Services in Papillion

Papillion, Nebraska – Local Plumbing and Drain Company continues to serve the Papillion community by providing dependable plumbing solutions designed to keep residential and commercial systems functioning efficiently. With a focus on reliability and professional workmanship, the company remains committed to helping customers maintain safe and effective plumbing systems through a range of essential services.

Houston Knee Surgery Specialist Catherine Cahill MD Highlights Modern Approaches to Knee Injury Treatment

Houston, TX – Knee injuries and chronic joint conditions can significantly affect mobility, daily activity, and overall quality of life. Catherine Cahill MD, a Houston-based orthopedic surgeon specializing in knee surgery, is highlighting modern treatment approaches designed to accurately diagnose knee problems and provide effective solutions that help patients return to an active lifestyle. Knee

Bronstein, Gewirtz & Grossman, LLC Encourages CTO Realty Growth, Inc. (CTO) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities prior to February 18, 2021, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cytokinetics, Incorporated (CYTK) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK). Investors who purchased Cytokinetics securities prior to December 27, 2023, and continue to hold to the present, are encouraged to obtain additional

Scroll to Top